GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer
GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer
Recruiting · NCT05575804 · Registry updated 2026-07-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer | Advanced/ Metastatic Her-2 Positive Breast Cancer | Recruiting | Phase 1 / Phase 2 | 2026-07-24 | NCT05575804 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
| GeneQuantum Healthcare (Suzhou) Co., Ltd. | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 257 |